Stroke / Neuro Critical Care
Comprehensive Stroke CareOpens new window | Adult Clinical Trials Main Page
Further protocol information can be found on the links below at ClinicalTrials.gov
Active Trials
Title: A Phase 2 Double Blinded, Randomized, Placebo Controlled Dose Escalation Study to Evaluate the Efficacy and the Safety of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within an 18-hour Treatment Window
Description: Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours (GMAIS)
Investigator: Nobl Barazangi, MD
Eligibility: Subjects with Acute Middle Cerebral Artery Ischemic Stroke who can be treated within an 18-hour treatment window
Status: Active and open to enrollment
Contact: Katie Ponting, 415-600-1163,
Email: PontinK@cpmcri.org about Study GMAIS
Title: Advancing Telestroke Care: A Prospective Observational Study
Description: The Advancing Telestroke Care study will establish treatment and outcomes in three distinct study cohorts: hub telemedicine hospital, spoke telemedicine hospital and non-telemedicine control hospital.
Investigator: Nobl Barazangi, MD
Eligibility: Subjects with Acute Ischemic Stroke
Status: Active and open to enrollment
Contact: Chanel Durley, 415-600-3246,
Email: DurleyC@cpmcri.org about Study Telemedicine
Title: Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Description: Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Investigator: Nobl Barazangi, MD
Eligibility: 18 years of age and older with the ability to randomize within 12 hours of symptom onset
Status: Active and open to enrollment
Contact: Katie Ponting, 415-600-1163,
Email: PontinK@cpmcri.org about Study POINT
Title: Expanding the Time Window for IV Thrombolysis with rt-PA in Acute Ischemic Stroke Patients Using Computed Tomography Perfusion Imaging: The PERFusion Use in Stroke Evaluation (PERFUSE) Study
Description: Patients with ischemic stroke who can be treated within six hours of symptom onset
Investigator: Nobl Barazangi, MD
Eligibility: Acute Ischemic Stroke (AIS) patients, ≥ 18 years old, who present up to 6 hours from time of onset of acute stroke symptoms
Status: Active and open to enrollment
Contact: Chanel Durley, 415-600-3246,
Email: DurleyC@cpmcri.org about Study PERFUSE
- updated October 2012
Back to top